$CME Income Statement | Understand Stock

$CME

$308.06 +$2.35 (0.77%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Clearing and Transaction Fees
MarketData
OtherRevenue
Total Revenues
Expenses
Compensation and benefits
Technology
Professional fees and outside services
Amortization of purchased intangibles
Depreciation and amortization
Licensing and other fee agreements
Other
Total Expenses
Operating Income
Non-Operating Income (Expense)
Investment income
Interest and other borrowing costs
Equity in net earnings (losses) of unconsolidated subsidiaries
Other income (expense)
Total Non-Operating
Income before Income Taxes
Income tax provision
Net income
Net Income (Loss) Attributable to Noncontrolling Interest
Net income attributable to CME Group
Net Income Attributable to Common Shareholders of CME Group
Earnings per Common Share Attributable to CME Group:
Basic
Diluted
Weighted Average Number of Common Shares:
Basic
Diluted

Comments